Estrogenic compounds as anti-mitotic agents

Details Estrogenic compounds as anti-mitotic agents Estrogenic compounds as anti-mitotic agents

2005-06-21

2005-06-21

Badio, Barbara P. (Department: 1616)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

C514S912000

Reexamination Certificate

active

06908910

ABSTRACT:
The application discloses methods of treating mammalian diseases characterized by abnormal cell mitosis by administering estradiol derivatives including those comprising colchicine or combretastatin A-4 structural motifs of the general formulae found below in a dosage sufficient to inhibit cell mitosis. The application discloses novel compounds used in the methods.

REFERENCES:
patent: 3166577 (1965-01-01), Ringold et al.
patent: 3562260 (1971-02-01), De Ruggieri et al.
patent: 4552758 (1985-11-01), Murphy et al.
patent: 4634705 (1987-01-01), DeBernardis et al.
patent: 4808402 (1989-02-01), Leibovich et al.
patent: 5015629 (1991-05-01), diZerega
patent: 5504074 (1996-04-01), D'Amato et al.
patent: 5661143 (1997-08-01), D'Amato et al.
patent: 6528676 (2003-03-01), D'Amato et al.
patent: 2002/0058612 (2002-05-01), Franco
patent: 2003/0175961 (2003-09-01), Herron
patent: 0166937 (1986-08-01), None
patent: 857080 (1960-12-01), None
patent: 857081 (1960-12-01), None
patent: 1570597 (1980-07-01), None
patent: 39005480 (1964-04-01), None
patent: 41 000100 (1966-01-01), None
patent: 42-928 (1967-01-01), None
patent: 58-131978 (1983-08-01), None
patent: 63-119500 (1988-05-01), None
patent: 1240038 (1996-10-01), None
patent: WO 87/02367 (1987-04-01), None
patent: WO 88/08002 (1988-10-01), None
patent: WO 93/19746 (1993-10-01), None
Simons, General concepts of angiogenesis.
Benedict et al., Annals of Internal Medicine, vol. 136(a), pp. 54-71, 2002.
Seegers et al., “The cytotoxic effects of estradio-17.beta. catecholestradiols and methoxyestradiols on dividing MCF-7 and HeLa cells.” J. Steroid Biochem., vol. 32(6), pp. 797-809, 1989.
Research Plus Catalog, pp.: 50-58, 1993.
Registry No.: 56933-77-8,Chemical Abstracts.
Registry No.: 56933-78-9,Chemical Abstracts.
Registry No.: 57380-15-1,Chemical Abstracts.
Registry No.: 71782-94-0,Chemical Abstracts.
Registry No.: 71782-95-1,Chemical Abstracts.
Registry No.: 101277-11-6,Chemical Abstracts.
Registry No.: 101429-40-7,Chemical Abstracts.
Registry No.: 162853-20-5,Chemical Abstracts.
Aboulwafa et al., Synthesis and evaluation for uterotrophic and antiimplantation activities of 2-substituted estradiol derivatives,Steroids, vol.: 57, pp.: 199-204, Apr. 1992.
Algire, G.H. et al., Vascular reactions of normal and malignant tumors in vivo. I. Vascular reactions of mice to wounds and to normal and neoplastic transplants,Journal of the National Cancer Institute, vol.: 6, pp.: 73-85, Aug. 1945.
Aliev et al., 54929q Synthesis of cycloalkyl derivatives of dihydric phenols and their ethers,Chemical Abstracts, vol.: 72, pp.: 370, 1970.
Barnes et al., Tumor Necrosis Factor Production in Patients with Leprosy,Infection and Immunity, vol.: 60 (4), pp.: 1441-1446, Apr. 1992.
Bindra et al., Studies in Antifertility Agents.8.Seco Steroids. 2. 5,6-Secoestradiol and Some Related Compounds,Journal of Medicinal Chemistry, vol.: 18 (9), pp.: 921-925, 1975.
Blickenstaff et al., Synthesis of Some Analogs of Estradiol,Steriods, vol.: 46 (4,5), pp.: 889-902, Oct. 1985.
Boyce et al., Some Preliminary Synthetical Studies with 5,6,7,8-Tetra-hydro-8-methylindane-1,5-dione,Unknown, pp.: 4547-4553, 1960.
Brandi et al., Bone endothelial cells as estrogen targets (Abstract only),Calcif. Tissue Int., vol.: 53 (5), pp.: 312-317, 1993.
Brem, H. et al., Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas,Journal of Neurosurgery, vol.: 74, pp.: 441-446, Mar. 1, 1991.
Cambie et al., Aromatic Steroids. Part I. Oxidation Products of 3-Methoxyestra-1,3,5(10)-triene- 17βyl Acetate,J. Chem. Soc., pp.: 2603-2608, 1968.
Corey et al., Applications of N,N-Dimethylhydrazones to Synthesis. Use in Efficient, Positionally and Stereochemically Selective C-C Bond Formation; Oxidative Hydrolysis to Carbonyl Compounds,Tetrahedron Letters, pp.: 3-6, 1976.
Corey et al., Facile Conversion of N,N-Dimethylhydrazones to Cabonyl Compounds by Cupric Ion-Catalyzed Hydrolysis,Tetrahedron Letters, vol.: 41, pp.: 36678-3668, 1976.
Crabbe, P., Cotton effect of the styrene chromophore (Abstract only),Chem. Ind., vol.: 27, pp.: 917-918, 1969.
Durani et al., Seco-Oestradiols and Some Non-Steroidal Oestsrogens: Structural Correlates of Oestrogenic Action,Journal of Steroid Biochemistry, vol.: 11, pp.: 67-77, 1979.
Eder et al., Synthese von Ostradiol (in German—No translation available),Chem. Ber., vol.: 109, pp.: 2948-2953, 1976.
Emons et al., Modulation der hypophysaren Sekretion von Luteinisierendem Hormon (LH) durch Ostrogene,Focus MHL, English Summary Only, vol.: 3, pp.: 221-228, 1986.
Fanchenko et al., Characteristics of the guinea pig uterus estrogen receptor system (Abstract only),Byull. Eksp. Biol. Med., vol.: 85 (4), pp.: 467-470, 1978.
Fevig et al., A Short, Stereoselective Route to 16α(Substituted-alkyl)estradiol Derivatives,Journal of Organic Chemistry, vol.: 52, pp.: 247-251, 1987.
Field et al., Effect of Thalidomide on the Graft versus Host Reaction,Nature, vol.: 211 (5055), pp.: 1308-1310, Sep. 17, 1966.
Fieser et al., N-Methylformanilide,Organic Synthesis Collective vol. 3, vol.: 3, pp.: 590-591, 1955.
Flohe et al., Studies on the Hypothetical Relationship of Thalidomide-induced Embryopathy and Collagen Biosynthesis,Arzncimitte/Forschung(Germany West), vol.: 31 (2), pp.: 315-320, Jan. 1, 1981.
Folkman et al., Angiogenesis Inhibition and Tumor Regression Caused by Heparin or a Heparin Fragment in the Presence of Cortisone,Science, vol.: 221, pp.: 719-725, Aug. 19, 1983.
Folkman, J., Tumor Angiogenesis: Therapeutic Implications,New England Journal of Medicine, vol.: 285 (21), pp.: 1182-1186, Nov. 18, 1971.
Folkman, J. et al., Induction of Angiogenesis During the Transition from Hyperplasia to Neoplasia,Nature, vol.: 339, pp.: 58-61, May 4, 1989.
Folkman, J. et al., Tumor Behavior in Isolated Perfused Organs in vitro Growth and Metastases of Biopsy Material in Rabbit Thyroid and Canine Intestinal Segment,Annals of Surgery, vol.: 164(3), pp.: 491-502, Sep. 1, 1966.
Gandhi et al., Mannich reaction of estrone,Journal of Indian Chem. Soc., vol.: 39, pp.: 306-308, 1962.
Gaslini et al., Reaction of Eugenol with Synthesis Gas. Synthesis of 5,6,7,8-Tetrahydro-3-methoxy-2-napthol,Journal of Organic Chemistry, vol.: 29 (5), pp.: 1177-1180, May 1964.
Gimbrone, M.A. et al., Tumor Growth and Neovascularization: An Experimental Model Using the Rabbit Cornen,Journal of the National Cancer Institute, vol.: 52(2), pp.: 413-427, Feb. 1974.
Gimbrone, M.A. et al., Tumor dormancy in vivo by Prevention of Neovascularization,Journal of Experimental Medicine, vol.: 136, pp.: 261-276, 1972.
Gonzalez et al., Synthesis and Pharmacological Evaluation of 8αEstradiol Derivatives,Steroids, vol.: 40 (2), pp.: 171-187, Sep. 1982.
Gross, J.L. et al., Modulation of Solid Tumor Growth in vivo by bFGF (Abstract only),Proceedings of the American Association of Cancer Research, vol.: 31, pp.: 79, Mar. 1990.
Gunzler, V., Thalidomide-A Therapy for the Immunological Consequences of HIV Infection?,Medical Hypothesis, vol.: 30 (2), pp.: 105-109, Oct. 1989.
Gupta et al., Antifertility Agents. XIV. Secosteroids. VII. Synthesis of 2αand 2β, 6β-dimethyl- 3β-(p-hyroxyphenyl)-trans-bicyclo[4.3.0]nonan-7-ones and some related compounds (Abstract only),Indian Journal of Chemistry, vol.: 13 (7), pp.: 759-760, 1975.
Gupta et al., Studies in Antifertility Agents. Part XVIII. 2q6β-Diethyl-3β-(p-hydroxyphenyl)-trans-bicyclo[4.3.0]nonan-7β-ol and 6β-methyl-3β-(p-hydroxyphenyl)-2α-propyl- trans-bicyclo[4.3.0]nonan-7βol (Abstract only),Indian Journal of Chemistry, vol.: 19B (10), pp.: 886-890, 1980.
Gutierrez-Rodriguez et al., Treatment of Refractory Rheumatoid Arthritis—The Thalidomide Experience,The Journal of Rheumatology, vol.: 16 (2), pp.: 158-163, Feb. 1989.
Gutierrez-Rodriguez, O., Thalidomide—A Promising New Treatment for Rheumatoid Arthritis,Arthritis and Rheumatism, vol.: 27 (10), pp.: 1118-1121, Oct. 1984.
Hahnel et al., The Specificity of the Estrogen Receptor of Human Uterus,Journal of Steroid

Affiliated with

Also associated with

Rating

Estrogenic compounds as anti-mitotic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Estrogenic compounds as anti-mitotic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Estrogenic compounds as anti-mitotic agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3490875